Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis

Fig. 6

Prognostic Analysis of the Characteristic Model of DR-DEGs. a PCA plot based on risk score; b t-SNE map based on risk score; c Kaplan–Meier analysis curve of prognosis related to high and low risk groups; d Time-dependent ROC curve, the area under the curve (AUC) at 1 year, 3 years, and 5 years is 0.626, 0.620, 0.623

Back to article page